Ambaw Bellete - Oct 4, 2024 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
President and COO
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Ambaw Bellete
Stock symbol
CGON
Transactions as of
Oct 4, 2024
Transactions value $
$0
Form type
4
Date filed
10/7/2024, 05:00 PM
Previous filing
Jan 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGON Stock Option (Right to Buy) Award $0 +176K $0.00 176K Oct 4, 2024 Common Stock 176K $36.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly following October 4, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.